Modulation of STAT3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and Chemoprevention
出版年份 2020 全文链接
标题
Modulation of STAT3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and Chemoprevention
作者
关键词
-
出版物
Cells
Volume 9, Issue 4, Pages 858
出版商
MDPI AG
发表日期
2020-04-02
DOI
10.3390/cells9040858
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cell Cycle and DNA Repair Regulation in the Damage Response: Protein Phosphatases Take Over the Reins
- (2020) Adrián Campos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Potentiation of Low-Dose Doxorubicin Cytotoxicity by Affecting P-Glycoprotein through Caryophyllane Sesquiterpenes in HepG2 Cells: an in Vitro and in Silico Study
- (2020) Di Sotto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps
- (2019) Silvia Di Giacomo et al. ARCHIVES OF TOXICOLOGY
- Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
- (2019) Chin-Yap Loh et al. Frontiers in Oncology
- Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization
- (2019) Sreevidya Mallappa et al. MOLECULAR CARCINOGENESIS
- Signaling networks in cholangiocarcinoma: molecular pathogenesis, targeted therapies and drug resistance
- (2019) Laura Fouassier et al. LIVER INTERNATIONAL
- Medical treatment for cholangiocarcinoma
- (2019) Jorge Adeva et al. LIVER INTERNATIONAL
- Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy
- (2019) Elisa Lozano et al. HEPATOLOGY
- Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines
- (2019) Tânia Capelôa et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- β-caryophyllene, a dietary phytocannabinoid attenuates oxidative stress, inflammation, apoptosis and prevents structural alterations of the myocardium against doxorubicin-induced acute cardiotoxicity in rats: An in vitro and in vivo study
- (2019) Hasan Al-Taee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hypoglycemic, Antiglycation, and Cytoprotective Properties of a Phenol-Rich Extract From Waste Peel of Punica granatum L. var. Dente di Cavallo DC2
- (2019) Antonella Di Sotto et al. MOLECULES
- Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma
- (2019) Jong Hyun Lee et al. Biomolecules
- Targeting DNA repair in cancer: current state and novel approaches
- (2019) Apostolos Klinakis et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- β-Caryophyllene Reduces DNA Oxidation and the Overexpression of Glial Fibrillary Acidic Protein in the Prefrontal Cortex and Hippocampus of d-Galactose-Induced Aged BALB/c Mice
- (2019) Paulina Chávez-Hurtado et al. JOURNAL OF MEDICINAL FOOD
- Cellular and molecular mechanisms of liver regeneration: Proliferation, growth, death and protection of hepatocytes
- (2019) Michitaka Ozaki SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- β-Caryophyllene promotes oxidative stress and apoptosis in KB cells through activation of mitochondrial-mediated pathway – An in-vitro and in-silico study
- (2019) Duraisamy Ramachandhiran et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Attenuation of STAT3 Signaling Cascade by Daidzin Can Enhance the Apoptotic Potential of Bortezomib against Multiple Myeloma
- (2019) Min Hee Yang et al. Biomolecules
- Chemoresistance and chemosensitization in cholangiocarcinoma
- (2018) Jose J.G. Marin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity
- (2018) Guifang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Role of lactoferrin and its receptors on biliary epithelium
- (2018) Romina Mancinelli et al. BIOMETALS
- Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer
- (2018) Jin-Young Lee et al. CANCER LETTERS
- Natural compounds and combination therapy in colorectal cancer treatment
- (2018) A. Rejhová et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Caryophyllane sesquiterpenes inhibit DNA-damage by tobacco smoke in bacterial and mammalian cells
- (2018) Silvia Di Giacomo et al. FOOD AND CHEMICAL TOXICOLOGY
- Synergistic interaction of β-caryophyllene with aromadendrene oxide 2 and phytol induces apoptosis on skin epidermoid cancer cells
- (2018) P.S. Pavithra et al. PHYTOMEDICINE
- Non-clinical toxicity of β -caryophyllene, a dietary cannabinoid: Absence of adverse effects in female Swiss mice
- (2018) George Laylson da Silva Oliveira et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Molecular bases of the poor response of liver cancer to chemotherapy
- (2018) Jose J.G. Marin et al. Clinics and Research in Hepatology and Gastroenterology
- Effects of β-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions
- (2018) Li Zhou et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Ophiopogonin D, a Steroidal Glycoside Abrogates STAT3 Signaling Cascade and Exhibits Anti-Cancer Activity by Causing GSH/GSSG Imbalance in Lung Carcinoma
- (2018) Jong Lee et al. Cancers
- SPC Liposomes as Possible Delivery Systems for Improving Bioavailability of the Natural Sesquiterpene β-Caryophyllene: Lamellarity and Drug-Loading as Key Features for a Rational Drug Delivery Design
- (2018) Antonella Di Sotto et al. Pharmaceutics
- EGFR-mediated apoptosis via STAT3
- (2017) Nicole M. Jackson et al. EXPERIMENTAL CELL RESEARCH
- Signaling pathways as therapeutic targets in biliary tract cancer
- (2017) Jennifer Yang et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma
- (2017) Massimiliano Cadamuro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by Doxorubicin
- (2017) Ernestina M. De Francesco et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cholangiocarcinoma — evolving concepts and therapeutic strategies
- (2017) Sumera Rizvi et al. Nature Reviews Clinical Oncology
- Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
- (2017) Donato Cappetta et al. Oxidative Medicine and Cellular Longevity
- Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
- (2017) Akiho Fukuda et al. PLoS One
- Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma
- (2016) Nestor F. Esnaola et al. CANCER
- Combinatorial immunotherapy strategies for hepatocellular carcinoma
- (2016) Maria Tagliamonte et al. CURRENT OPINION IN IMMUNOLOGY
- The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice
- (2016) Nan Wu et al. HEPATOLOGY
- Toxicological Evaluation of β-Caryophyllene Oil
- (2016) D. Schmitt et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
- (2016) Roberta Visconti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- β-caryophyllene andβ-caryophyllene oxide-natural compounds of anticancer and analgesic properties
- (2016) Klaudyna Fidyt et al. Cancer Medicine
- Two repeated low doses of doxorubicin are more effective than a single high dose against tumors overexpressing P-glycoprotein
- (2015) Chiara Riganti et al. CANCER LETTERS
- Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway
- (2015) Jong Hyun Lee et al. CANCER LETTERS
- β-Caryophyllene potently inhibits solid tumor growth and lymph node metastasis of B16F10 melanoma cells in high-fat diet–induced obese C57BL/6N mice
- (2015) Jae In Jung et al. CARCINOGENESIS
- Mutagenicity of cigarette butt waste in the bacterial reverse mutation assay: The protective effects of β-caryophyllene and β-caryophyllene oxide
- (2015) Silvia Di Giacomo et al. ENVIRONMENTAL TOXICOLOGY
- The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllene from the Essential Oil of Aquilaria crassna
- (2015) Saad Dahham et al. MOLECULES
- Interaction of β-caryophyllene and β-caryophyllene oxide with phospholipid bilayers: Differential scanning calorimetry study
- (2015) Maria Grazia Sarpietro et al. THERMOCHIMICA ACTA
- ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
- (2015) J. Shen et al. Cancer Discovery
- Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
- (2014) Ho-June Lee et al. CANCER CELL
- STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression
- (2014) Hasaya Dokduang et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo
- (2014) Gautam Sethi et al. Molecular Cancer
- β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
- (2014) Amine Bahi et al. PHYSIOLOGY & BEHAVIOR
- β-Caryophyllene oxide potentiates TNFα-induced apoptosis and inhibits invasion through down-modulation of NF-κB-regulated gene products
- (2013) Chulwon Kim et al. APOPTOSIS
- β-caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase
- (2013) Chulwon Kim et al. MOLECULAR CARCINOGENESIS
- Genotoxicity assessment of β-caryophyllene oxide
- (2013) Antonella Di Sotto et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Expression of Multidrug Resistance-Associated Protein 2 in Human Gallbladder Carcinoma
- (2013) Hyun-Soo Kim et al. Biomed Research International
- Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection
- (2012) Martin Štěrba et al. ANTIOXIDANTS & REDOX SIGNALING
- Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network
- (2012) Anne Trécul et al. Genes and Nutrition
- No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
- (2012) P. Martinez-Becerra et al. MOLECULAR PHARMACEUTICS
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin
- (2012) Ji-Eon Kim et al. XENOBIOTICA
- β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation
- (2011) Kyung-Ran Park et al. CANCER LETTERS
- Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways
- (2011) S. Prakobwong et al. CARCINOGENESIS
- Possibilities to increase the effectiveness of doxorubicin in cancer cells killing
- (2011) Veronika Hanušová et al. DRUG METABOLISM REVIEWS
- Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1
- (2011) Peramaiyan Rajendran et al. JOURNAL OF CELLULAR PHYSIOLOGY
- STAT3 SIGNALING: Anticancer Strategies and Challenges
- (2011) P. A. Johnston et al. MOLECULAR INTERVENTIONS
- Galactosylated α,β-poly[(2-hydroxyethyl)-L-aspartamide]-bound doxorubicin
- (2010) Xiaoyun Cheng et al. ANTI-CANCER DRUGS
- γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
- (2010) Peramaiyan Rajendran et al. BRITISH JOURNAL OF PHARMACOLOGY
- Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo
- (2010) Peramaiyan Rajendran et al. CLINICAL CANCER RESEARCH
- Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas
- (2010) S. Rau et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Synergy research: Approaching a new generation of phytopharmaceuticals
- (2010) Hildebert Wagner FITOTERAPIA
- STAT3 modulates the DNA damage response pathway
- (2010) Seán P. Barry et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Inhibition by β-caryophyllene of ethyl methanesulfonate-induced clastogenicity in cultured human lymphocytes
- (2010) Antonella Di Sotto et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Clastogenicity of Beta-Caryophyllene in Mouse
- (2009) Dolores Molina-Jasso et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression
- (2009) Giammarco Fava et al. LIVER INTERNATIONAL
- Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay
- (2008) Antonella Di Sotto et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started